Basics Zevra Therapeutics, Inc. IPO Date: April 13, 2015 Sector: Healthcare Industry: Biotech Market Cap: $699.35M Activated in VL: True Average Daily Range Avg Daily Range: $0.16 | 2.52% Avg Daily Range (30 D): $0.23 | 2.19% Avg Daily Range (90 D): $0.20 | 2.37% Institutional Daily Volume Avg Daily Volume: .4M Avg Daily Volume (30 D): .98M Avg Daily Volume (90 D): .64M Trade Size Avg Trade Size (Sh.): 92 Avg Trade Size (Sh.) (30 D): 86 Avg Trade Size (Sh.) (90 D): 82 Institutional Trades Total Inst.Trades: 97 Avg Inst. Trade: $1.46M Avg Inst. Trade (30 D): $1.13M Avg Inst. Trade (90 D): $1.23M Avg Inst. Trade Volume: .19M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.1M Avg Closing Trade (30 D): $1.17M Avg Closing Trade (90 D): $1.3M Avg Closing Volume: 277.18K     News Feb 27, 2025 @ 12:30 PM Zevra Therapeutics Enters Agreement to Sell its Ra... Source: Globe Newswire Dec 6, 2024 @ 10:00 PM Zevra Therapeutics Announces Organizational Change... Source: N/A Nov 21, 2024 @ 9:51 PM Zevra Therapeutics Announces U.S. Commercial Avail... Source: N/A Nov 11, 2024 @ 9:36 PM Zevra Therapeutics to Present Data Demonstrating R... Source: Zevra Therapeutics, Inc. Aug 2, 2024 @ 9:50 PM FDA Advisory Committee Votes Favorably that the Da... Source: Zevra Therapeutics, Inc. Financials   TTM Q4 2024 FY 2024 Basic EPS $-.06 $-.69 $-2.28 Diluted EPS Revenue $ 20.4M $ 12.04M $ 23.61M Gross Profit $ $ $ Net Income / Loss $ -3.1M $ -35.74M $ -105.51M Operating Income / Loss $ -5.36M $ -15.42M $ -87M Cost of Revenue $ $ $ Net Cash Flow $ 3.93M $ -20.93M $ -9.72M PE Ratio     Splits Dec 28, 2020:   1:16